Alethio Therapeutics Limited

#13509030 Active

Alethiomics is dedicated to uncovering new biological insights to discover and develop innovative treatments for patients suffering from blood cancer. Their research focuses on single cells and novel targets to advance therapeutic options.

Founded: 13 Jul 2021
Industries:
72110 - Research and experimental development on biotechnology
Location: Abingdon

Products & Services

• biological insights
• biological research
• biotechnology
• blood cancer
• life-changing treatments for blood cancer
• research and development
• therapeutics
• treatment development

Financial Snapshot

Last accounts made up to 31 Dec 2024
Next accounts due 30 Sept 2026 (8 months)
Cash in Bank
£0.34m
↓ 23%
Turnover
£2.1m
↑ 15%
EBITDA
£0.45m
↑ 8%
Gross Profit
£0.89m
↑ 12%
Total Liabilities
£0.72m
↓ 17%
Employees
14
↑ 0%
Unlock financial data with Pro Start Free Trial →

People

Officers
6
Shareholders
5
Controllers (PSC)
3
Bethan Psaila
Director • British • Lives in England • Born in Mar 1979
Mark Throsby
Director • Australian • Lives in Netherlands • Born in Mar 1967
Sally Marianne Dewhurst
Director • British • Lives in United Kingdom • Born in Mar 1990
Suman Shirodkar
Director • American • Lives in Switzerland • Born in Oct 1965
Rohit Batta
Director • British • Lives in United Kingdom • Born in Jun 1977

Registered Office Address

Sovereign House, Abingdon Science Park

Barton Lane

Abingdon

OX14 3NB

England

Basic Information

LTD
13 Jul 2021
ENGLAND WALES
Yes

Industry Classification

72110

Company Attributes

N/A
N/A
N/A
N/A

Summary

10
Officers
3
PSCs
0
Filings